A question about the potential cardiac toxicity of Escitalopram

Journal of Psychosocial Nursing and Mental Health Services

Volumn 50, Issue 4, 2012, Pages 17-20

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860128715     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20120307-02     Document Type: Review

References (16)

1. de Leon, J. (2007). The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ul-trarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 and CYP2C19. Journal of Clinical Psychopharma-cology, 27, 241-245.
2. Desta, Z., Zhao, X., Shin, J.G., & Flockhart, D.A. (2002). Clinical signifcance of the cytochrome P450 2C19 genetic polymorphism. Clinical Pharmacokinetics, 41, 913-958.
3. Forest Pharmaceuticals, Inc. (2011). Lexa-pro product package insert. Retrieved from http://www.frx.com/pi/lexapro_pi.pdf
4. Hansen, B.H., Hanash, J.A., Rasmussen, A., Hansen, J.F., & Birket-Smith, M. (2009). Rationale, design, and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD). Trials, 10. Retrieved from http://www.trialsjournal.com/ content/10/1/20. doi:10.1186/1745-6215-10-20
5. Hayes, B.D., Klein-Schwartz, W., Clark, R.F., Muller, A.A., & Miloradovich, J.E. (2010). Comparison of toxicity of acute overdoses with citalopram and escitalopram. Journal of Emergency Medicine, 39, 44-48. doi:10.1016/j.jemermed.2008.06.030
6. Herrlin, K., Yasui-Furukori, N., Tybring, G., Widén, J., Gustafsson, L.L., & Bertilsson, L. (2003). Metabolism of citalopram enan-tiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. British Journal of Clinical Pharmacology, 56, 415-421.
7. Howland, R.H. (2011a). A critical evaluation of the cardiac toxicity of citalopram- Part 1. Journal of Psychosocial Nursing and Mental Health Services, 49(11), 13-16. doi:10.3928/02793695-20111011-01
8. Howland, R.H. (2011b). A critical evaluation of the cardiac toxicity of citalopram- Part 2. Journal of Psychosocial Nursing and Mental Health Services, 49(12), 13-16. doi:10.3928/02793695-20111102-04
9. Kasper, S., de Swart, H., & Andersen, H.F. (2005). Escitalopram in the treatment of depressed elderly patients. American Journal of Geriatric Psychiatry, 13, 884-891.
10. Kasper, S., Lemming, O.M., & de Swart, H. (2006). Escitalopram in the long-term treatment of major depressive disorder in elderly patients. Neuropsychobiology, 54, 152-159. doi:10.1159/000098650
11. Le Bloc'h, Y., Woggon, B., Weissenrieder, H., Brawand-Amey, M., Spagnoli, J., Eap, C.B., & Baumann, P. (2003). Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram. Therapeutic Drug Monitoring, 25, 600-608.
12. Luo, S., Michler, K., Johnston, P., & Macfarlane, P. W. (2004). A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs. Journal of Electrocardiology, 37(Suppl.), 81-90. doi:10.1016/j.jelectrocard.2004.08.030
13. Reis, M., Cherma, M.D., Carlsson, B., & Bengtsson, F. (2007). Therapeutic drug monitoring of escitalopram in an outpatient setting. Therapeutic Drug Monitoring, 29, 758-766.
14. Søgaard, B., Mengel, H., Rao, N., & Lars-en, F. (2005). The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. Journal of Clinical Pharmacology, 45, 1400-1406. doi:10.1177/0091270005280860
15. Tseng, P.-T., Lee, Y., Lin, Y.-E., & Lin, P.-Y. (2012). Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: A case report and literature review. General Hospital Psychiatry, 34, 210.e13-210.e15. doi:10.1016/j.genhosppsych.2011.10.005
16. van Gorp, F., Whyte, I.M., & Isbister, G.K. (2009). Clinical and ECG effects of escitalopram overdose. Annals of Emergency Medicine, 54, 404-408. doi:10.1016/j.annemergmed.2009.04.016